A. Bougouin

发表

Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers.

I. Soubeyran, A. Italiano, W. Fridman, 2023, Laboratory investigation; a journal of technical methods and pathology.

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

I. Soubeyran, C. Sautès-Fridman, M. Toulmonde, 2021, Nature Cancer.

1451MO In-situ immune markers predict nivolumab (N) +/-ipilimumab (I) efficacy in frontline metastatic clear cell renal cell carcinoma (mccRCC): Key ancillary analyses from the BIONIKK randomized trial

C. Tournigand, C. Sautès-Fridman, S. Oudard, 2022, Annals of Oncology.

Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s

P. Validire, C. Sautès-Fridman, Guillaume Lacroix, 2021, Cancer Immunology Research.